New York, April 24, 2024 - PRISM MarketView - Oil and gas company Verde Bio (VBHI) issued an update regarding its pending merger with SensaSure Technologies (SSTC). In the update the company announced that the registration statement on Form S-4 has been declared effective by the Securities and Exchange Commission. A special meeting will be held for each company’s shareholders on May 9th 2024. The shareholders who have been sent the Proxy Statement/Prospectus are urged to read the document and vote “FOR” ALL PROPOSALS ahead of the special meetings by phone, Internet or by proxy card. Further information on this matter can be found in the official release.
The merger is expected to close by the end of May 2024.
About SensaSure Technologies, Inc.
Until November 2023, SensaSure Technologies, Inc. (OTCQB: SSTC) was a medical technology or “MedTech” company that supplied a simple device and method to collect a breath sample for lab-based analysis. Subsequent to the six months ended October 31, 2023, management of SensaSure has been in the process of establishing a new business segment to develop energy related businesses which led to the entry into the pending Merger transaction.
About Verde Bio Holdings, Inc.
Verde Bio Holdings, Inc. (OTC: VBHI) is an oil and gas company engaged in the acquisition and management of mineral and royalty interests in lower risk, onshore oil and gas properties within the major oil and gas plays in the U.S. The Company’s dual-focused growth strategy relies primarily on leveraging management’s expertise to grow through the strategic acquisition of revenue producing royalty interest and strategic and opportunistic non-operated working interests.
About PRISM MarketView
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
Disclaimer:
PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
Contact:
Prism MarketView | Stock Market News & Investment Opportunities
PRISM MarketView - Social Media (X)